Wright Medical Gains FDA Premarket Approval for AUGMENT Injectable Bone Graft

Wright Medical (WMGI) received FDA premarket approval for AUGMENT® Injectable Bone Graft, for the same clinical indications as AUGMENT® Bone Graft.  The combination product comprises recombinant human platelet derived growth factor (rhPDGF-BB) plus collagen and Beta tri-calcium phosphate, and serves as an alternative to autograft in hindfoot and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us